Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Altisent

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 31, 2008
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophiliaA Rentz, E Flood, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIIIM Gensana, C Altisent, J A Aznar, et al.
Medicina Clinica|March 25, 1995
[Progression of HIV infection in a cohort of hemophiliacs over an 11-year period]C Altisent Roca, A Ayestarán Altuna, J M Tusell Puigbert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2009
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendationsC Hermans, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experienceN Stieltjes, C Altisent, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2014
International cross-cultural validation study of the Canadian haemophilia outcomes: kids' life assessment toolP J McCusker, K Fischer, S Holzhauer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome dataM Richards, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia CentresM Morfini, G Auerswald, R A Kobelt, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1996
Glutathione and cysteine in HIV-infected hemophiliacsR M López Galera, J C Juárez Giménez, J B Montoro Ronsano, et al.
Haematologica|October 6, 1999
Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacsD Tàssies, M Magallón, M Quintana, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 31, 2008
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophiliaA Rentz, E Flood, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIIIM Gensana, C Altisent, J A Aznar, et al.
Medicina Clinica|March 25, 1995
[Progression of HIV infection in a cohort of hemophiliacs over an 11-year period]C Altisent Roca, A Ayestarán Altuna, J M Tusell Puigbert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2009
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendationsC Hermans, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experienceN Stieltjes, C Altisent, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2014
International cross-cultural validation study of the Canadian haemophilia outcomes: kids' life assessment toolP J McCusker, K Fischer, S Holzhauer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome dataM Richards, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia CentresM Morfini, G Auerswald, R A Kobelt, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1996
Glutathione and cysteine in HIV-infected hemophiliacsR M López Galera, J C Juárez Giménez, J B Montoro Ronsano, et al.
Haematologica|October 6, 1999
Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacsD Tàssies, M Magallón, M Quintana, et al.
Pageof 6